WHOCC
Postal address:
Norwegian Institute of Public Health
WHO Collaborating Centre for Drug Statistics Methodology
Postboks 222 Skøyen
0213 Oslo
Norway

Visiting/delivery address:
Myrens verksted 6H
0473 Oslo
Norway

Tel:  +47 21 07 81 60
E-mail:
 
Copyright/Disclaimer

New search    Hide text from Guidelines

C CARDIOVASCULAR SYSTEM

This group comprises substances used for the treatment of cardiovascular conditions.
Drugs used for the treatment of hypertension are classified in C02 - Antihypertensives, C03 - Diuretics, C07 - Beta blocking agents, C08 - Calcium channel blockers, and C09 - Agents acting on the renin-angiotensin system. For the classification of combination products of antihypertensives from different ATC groups, the following ranking should be used, from higher to lower precedence: C09, C07, C08, and C03.


C04 PERIPHERAL VASODILATORS
C04A PERIPHERAL VASODILATORS

This group comprises plain and combined preparations used in the treatment of cerebrovascular or peripheral circulatory disorders.
Combinations with Antihypertensives, see C02 - Antihypertensives.
Combinations with vasodilators used in cardiac diseases, see C01DA.

The DDDs are based on the doses used for the treatment of cerebral and peripheral vascular disorders.


C04AX Other peripheral vasodilators

Betahistine, cinnarizine and flunarizine are classified as antivertigo preparations in N07CA.
Papaverine preparations, see A03AD and G04BE.


Prostaglandin analogues used for pulmonary arterial hypertension or arteriosclerosis obliterans are classified in B01AC.


    ATC code  Name  DDD  U Adm.R Note
    C04AX27 cinepazide    

List of abbreviations

Last updated: 2024-01-26